Skip to Main Content
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase Research Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase Research Catalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase ResearchCatalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase ResearchCatalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Category: Cell and gene therapy
Blog Highlights of ASCO 2025 Translating research into real-world results for cancer patients I joined over 45,000 oncology professionals at McCormick Read Now Info Sheet Driving Innovation in Radiopharmaceutical Therapies Oncology clinical research is complex, demanding, and continually evolving. Bringing effective radiopharmaceutical therapies from proof-of-concept Read Now Info Sheet Developing Next-generation Therapies for Breast Cancer Patients Breast cancer is the second most common malignancy worldwide and the number one cancer in Read Now Info Sheet Helping to Develop Cell Therapies  Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now Woman at computer looking at screen with colleagues next to her. Press Release CRO Support for XRad Therapeutics XRad Therapeutics announced first patient dosed in Phase 1a clinical trial of XRD-0394 for metastatic, Read Now Two young business people discussing a project. Blog Partnership with Cell and Gene Therapy Catapult Aptus Clinical and Cell and Gene Therapy Catapult announce their clinical service collaboration to support Read Now
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.